Attributable causes of liver cancer mortality and incidence in China

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 12, 2013, Pages 7251-7256

  Fan, Jin Hu ^a   Wang, Jian Bing ^a,b   Jiang, Yong ^a   Xiang, Wang ^c   Liang, Hao ^a   Wei, Wen Qiang ^a   Qiao, You Lin ^a   Boffetta, Paolo ^d,e  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

China; Liver cancer; Population attributable fraction; Risk factors

Indexed keywords

CHINA; COMPLICATION; DRINKING BEHAVIOR; EPIDEMIOLOGY; FEMALE; FOLLOW UP; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; INCIDENCE; LIVER NEOPLASMS; MALE; MORTALITY; PATHOGENICITY; PROGNOSIS; RISK FACTOR; SMOKING; SURVIVAL RATE; VIROLOGY;

ALCOHOL DRINKING; CHINA; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; PROGNOSIS; RISK FACTORS; SMOKING; SURVIVAL RATE;

EID: 84893356353     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.12.7251     Document Type: Article

References (45)

1. Baan R, Grosse Y, Straif K, et al (2009). A review of human carcinogens-Part F: chemical agents and related occupations. Lancet Oncol, 10, 1143-4.
2. Boffetta P, Hashibe M, La Vecchia C, et al (2006). The burden of cancer attributable to alcohol drinking. Int J Cancer, 119, 884-7.
3. Calle EE, Rodriguez C, Walker-Thurmond K, et al (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med, 348, 1625-38.
4. Chen ZM, Liu BQ, Boreham J, et al (2003). Smoking and liver cancer in China: case-control comparison of 36, 000 liver cancer deaths vs. 17,000 cirrhosis deaths. Int J Cancer, 107, 106-12.
5. Chen WQ (2009). Estimation of cancer incidence and mortality in China in 2004-2005. Chin J Oncol, 31, 664-8.
6. Chen JG, Zhang SW, Chen WQ (2010). Analysis of liver cancer mortality in the national retrospective sampling survey of death causes in China, 2004-2005. Zhonghua Yu Fang Yi Xue Za Zhi, 44, 383-9.
7. Chuang SC, La Vecchia C, Boffetta P (2009). Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett, 286, 9-14.
8. Danaei G, Vander Hoorn S, Lopez AD, et al (2005). Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet, 366, 1784-93.
9. Darrow LA, Steenland NK (2011). Confounding and bias in the attributable fraction. Epidemiology, 22, 53-8.
10. de Martel C, Ferlay J, Franceschi S, et al (2012). Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol, 13, 607-15.
11. Ezzati M, Hoorn SV, Rodgers A, et al (2003). Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet, 362, 271-80.
12. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
13. Ge KY (1997). Body mass index of young Chinese adults. Asia nPacific J Clin Nutr, 6, 175-9.
14. Gu D, Kelly TN, Wu X, et al (2009). Mortality attributable to smoking in China. N Engl J Med, 360, 150-9.
15. Inoue M, Sawada N, Matsuda T, et al (2012). Attributable causes of cancer in Japan in 2005-systematic assessment to estimate current burden of cancer attributable to known preventable risk factors in Japan. Ann Oncol, 23, 1362-9.
16. International Agency for Research on Cancer, Académie des Sciences-Institut de France, Académie de Médecine, Fédération Nationale des Centres de Lutte contre le Cancer (2007). IARC Working Group Reports, Vol 3, Attributable Causes of Cancer in France in the Year 2000. Lyon: IARC Press.
17. Lai SW, Chen PC, Liao KF, et al (2012). Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study. Am J Gastroenterol, 107, 46-52.
18. Levin ML (1953). The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum, 9, 531-41.
19. Liang X, Bi S, Yang W, et al (2009). Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine, 27, 6550-7.
20. Liang H, Wang J, Xiao H, et al (2010). Estimation of cancer incidence and mortality attributable to alcohol drinking in China. BMC Public Health, 10, 730.
21. Liu BQ, Peto R, Chen ZM, et al (1998). Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ, 317. 1411-22.
22. Liu Y, Chang CC, Marsh GM, et al (2012). Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis. Eur J Cancer, 48, 2125-36.
23. Lu PX, Wang JB, Zhang QN, et al (2010). Longitudinal study of aflatoxin exposure in the development of primary liver cancer in patients with chronic hepatitis. Zhonghua Yi Xue Za Zhi, 90, 1665-9.
24. Ministry of Health of the People's Republic of China (2008). Report of the Third National Retrospective Survey of Death Causes in China. Beijing: Chinese Academy of Medical Sciences & Peking Union Medical College Press.
25. Olsen JH, Andersen A, Dreyer L, et al (1997). Summary of avoidable cancers in the Nordic countries. APMIS Suppl, 76, S141-6.
26. Omer RE, Kuijsten A, Kadaru AM, et al (2004). Populationattributable risk of dietary aflatoxins and hepatitis B virus infection with respect to hepatocellular carcinoma. Nutr Cancer, 48, 15-21.
27. Pan XR, Yang WY, Li GW, et al (1997). Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care, 20, 1664-9.
28. Parkin DM, Boyd L, Walker LC (2011). 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer, 105, S77-81.
29. Pei GJ, Fu L, Cui YL (2008). Meta-analysis on the association of hepatocellular carcinoma with alcohol drinking among Chinese people. Xian Dai Yu Fang Yi Xue, 35, 2626-7.
30. Polesel J, Zucchetto A, Montella M, et al (2009). The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol, 20, 353-7.
31. PRC National Blood Pressure Survey Cooperative Group (1995). Alcohol Consumption and Blood Pressure: A Nation-wide Survey of in 1991 in China. Chin J Hypert, 3, 50-4.
32. Rothman KJ (2012). Epidemiology: An introduction. 2nd edition. New York: Oxford University Press.
33. Shin A, Park S, Shin HR, et al (2011). Population attributable fraction of infection-related cancers in Korea. Ann Oncol, 22, 1435-42.
34. Wang JB, Jiang Y, Wei WQ, et al (2010). Estimation of cancer incidence and mortality attributable to smoking in China. Cancer Causes Control, 21, 959-65.
35. Wang JB, Jiang Y, Liang H, et al (2012a). Attributable causes of cancer in China. Ann Oncol, 23, 2983-9.
36. Wang C, Wang X, Gong G, et al (2012b). Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer, 130, 1639-48.
37. Weng XZ, Hong ZG, Chen DY (1987). Smoking prevalence in Chinese aged 15 and above. Chin Med J, 100, 886-92.
38. Wu HC, Wang Q, Yang HI, et al (2009). Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan. Cancer Epidemiol Biomarkers Prev, 18, 846-53.
39. Xia GL, Liu CB, Cao HL, et al (1996). Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992. Int Hepatol Commun, 5, 62-73.
40. Xiang W, Shi JF, Li P, et al (2011). Estimation of cancer cases and deaths attributable to infection in China. Cancer Causes Control, 22, 1153-61.
41. Yang G, Fan L, Tan J, et al (1999). Smoking in China: findings of the 1996 National Prevalence Survey. JAMA, 282, 1247-53.
42. Yang WS, Va P, Bray F, et al (2011). The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies. PLoS One, 6, e27326.
43. Yao HY, Yang NN, Fang Y, et al (2002). A comprehensive analysis on the risk factors of lung cancer, liver cancer and breast cancer. Zhongguo Zhong Liu, 11, 695-6.
44. Yu MC, Yuan JM (2004). Environmental factors and risk for hepatocellular carcinoma. Gastroenterology, 127, S72-8.
45. Zhou XY, Fang JQ (2002). The application of Gibbs sampling in meta-analysis for case-control studies of HBV, HCV and dual infection in primary hepatocelluar carcinoma. Zhongshan Yi Ke Da Xue Xue Bao, 23, 165-7.